CLX - The Clorox Company
| Previous Close | 162.47 |
| Open | 163.00 |
| Bid | 162.14 x 800 |
| Ask | 162.21 x 800 |
| Day's Range | 161.68 - 163.37 |
| 52 Week Range | 113.57 - 167.70 |
| Volume | 65,540 |
| Avg. Volume | 997,206 |
| Market Cap | 20.683B |
| Beta (3Y Monthly) | 0.31 |
| PE Ratio (TTM) | 25.24 |
| EPS (TTM) | 6.42 |
| Earnings Date | Jan 31, 2019 - Feb 4, 2019 |
| Forward Dividend & Yield | 3.84 (2.36%) |
| Ex-Dividend Date | 2019-01-22 |
| 1y Target Est | 142.93 |
- GuruFocus.com•3 days ago
Clorox Co (CLX) Chairman & CEO Benno O Dorer Sold $25.1 million of Shares
Chairman & CEO of Clorox Co (NYSE:CLX) Benno O Dorer sold 152,449 shares of CLX on 12/04/2018 at an average price of $164.83 a share.
Market Realist•4 days agoClorox Stock: Why the Uptrend Might Continue
Clorox (CLX) stock rose 11.6% in November due to the company’s better-than-expected first-quarter results. Clorox’s top line beat analysts’ expectation due to improved volumes and higher pricing. Incremental sales from the company’s recent acquisition supported the top-line growth rate. Clorox’s bottom line had double-digit growth and beat analysts’ expectations due to the lower effective tax rate.
Market Realist•4 days agoWhich CPG Stocks Outperformed the Markets in November?
Shares of major CPG (consumer packaged goods) manufacturers showed a healthy recovery in November and outperformed the benchmark index (SPX). Shares of Church & Dwight (CHD), Clorox (CLX), Kimberly-Clark (KMB), Procter & Gamble (PG), and Colgate-Palmolive (CL) increased 11.5%, 11.6%, 10.6%, 6.6%, and 6.7%, respectively, in November. In comparison, the S&P 500 Index increased 1.8% during the same period.
- Simply Wall St.•4 days ago
Is The Clorox Company’s (NYSE:CLX) High P/E Ratio A Problem For Investors?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use The Clorox Company's (NYSE:CLX) P/E Read More...
- TheStreet.com•6 days ago
Clorox Has Found Buyers in a Struggling Market
Those golden equity futures from Sunday night have turned to dust before most of us even had a chance to eat lunch on Tuesday. At this point, I believe investors, who want to be involved with equities, need to look towards the anti-economic growth names into consumer staples or the strength of the past few weeks.
- CNBC•7 days ago
Cramer Remix: These recession-proof stocks are worth buying on a pullback
CNBC's Jim Cramer highlights high-quality slowdown stocks that he says investors should consider buying gradually into weakness. The "Mad Money" host also sits down with the CEO of Groupon and "Deal or No Deal" host Howie Mandel. Stocks may have rebounded Monday on renewed hope for a trade deal between the U.S. and China, but CNBC's Jim Cramer still found value in some names that tend to do well during downturns.
- Investor's Business Daily•7 days ago
Stocks Rally On Tariff Timeout; Oil, Farm And Auto Plays Lead
The day's laggards included soap stocks, beverages, food, tobacco and utilities. Bulls welcomed the shift away from defensive issues.
- Benzinga•7 days ago
Pro: Consumer Goods Stocks Surging In 'Clear Change' In Market Leadership
Less exciting stocks like McCormick & Co (NYSE: MKC ) and Clorox co (NYSE: CLX ) are trading near their 52-week highs, and this marks a "clear change in leadership," according to Erin Gibbs , ...
- InvestorPlace•10 days ago
Don’t Buy the Headlines or Clorox Stock at All Right Now
Clorox (NYSE:CLX) stock has brought the company back in the headlines. After a 35% increase over the last six months, many wonder whether the time has come to buy Clorox stock. Household products stocks typically receive less attention than stocks like Amazon (NASDAQ:AMZN) or Tesla (NASDAQ:TSLA).
- CNBC•10 days ago
One corner of the market is quietly making new highs
While the rest of the market struggles to get back up to records, a handful of consumer staples stocks have quietly rallied to new highs.
- Zacks•10 days ago
Why Is Clorox (CLX) Up 8% Since Last Earnings Report?
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Market Realist•11 days agoWhy Wall Street Expects Downside in KMB Stock
Wall Street analysts maintain a target price of $105.65 per share on Kimberly-Clark (KMB) stock, which indicates a downside of 8.5%, based on its closing price of $115.45 on November 27. Analysts expect Kimberly-Clark’s soft sales and weak margins to hurt its stock in the near term. Kimberly-Clark’s top line is expected to decline in the next couple of quarters, reflecting adverse currency rates and challenging market conditions in China.
- Market Realist•11 days ago
Why KMB’s EPS Could Disappoint in the Near Term
Analysts expect Kimberly-Clark’s bottom line to take a hit from soft sales and cost headwinds in the near term. A higher tax rate is likely to affect the 2019 EPS growth rate. Analysts expect Kimberly-Clark to report adjusted earnings of $1.66 per share in the fourth quarter of 2018, which reflects year-over-year or YoY growth of 5.7%.
GuruFocus.com•12 days agoMS Global Franchise Fund's Top 5 Buys in 3rd Quarter
Fund adds to two existing positions and introduces three new holdings
Market Realist•12 days agoWhy Kimberly-Clark’s Margins Are Expected to Decline
Kimberly-Clark’s (KMB) profit margins remained weak in the first nine months of 2018, and the trend is likely to continue as challenges persist, at least in the near term. Kimberly-Clark’s management expects inflation in commodities, including pulp and other raw materials, to continue to hurt its gross margins despite the benefits from a favorable mix, higher pricing, and cost savings. Weak gross margins are likely to hurt operating margins during the fourth quarter.
- Market Realist•12 days ago
Why KMB’s Sales Are Projected to Fall in the Near Term
Wall Street expects Kimberly-Clark’s sales (KMB) to remain weak in the near term, at least over the next couple of quarters. Analysts expect Kimberly-Clark’s net sales to decline 2.7% in the fourth quarter of 2018. Meanwhile, its top line is forecast to fall 4.1% in the first quarter of 2019.
Market Realist•12 days agoWill Sales and Cost Headwinds Stall the Recovery in KMB Stock?
Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22. Kimberly-Clark’s third-quarter top and bottom lines came in ahead of analysts’ estimates, thanks to higher pricing, a favorable mix, a lower effective tax rate, and share repurchases.
- TheStreet.com•12 days ago
Clorox Shares Are Looking Still Brighter for the Months Ahead
Jim Cramer told his "Mad Money" viewers Tuesday evening that money managers are flocking to the recession stocks. , Cramer explained. In this daily bar chart of CLX, below, we can see how prices have trended higher from late April.
Markit•12 days agoSee what the IHS Markit Score report has to say about Clorox Co.
Clorox Co NYSE:CLX
- Zacks•14 days ago
Clorox (CLX) Gains 35% in 6 Months: Will the Rally Continue?
Clorox (CLX) benefits from its solid strategic efforts, including 2020 strategy, expansion of e-commerce capabilities and brand management initiatives.
Markit•18 days agoSee what the IHS Markit Score report has to say about Clorox Co.
Clorox Co NYSE:CLX
Market Realist•20 days agoHow CHD Has Outperformed Its Bigger Rivals This Year
Church & Dwight (CHD) stock has had a phenomenal run so far this year. Church & Dwight’s focus on innovation, incremental sales from recent acquisitions, investments in its international business, and a balanced portfolio of value and premium products drove its top line. Strong sales growth and tax reforms have driven Church & Dwight’s bottom line, which has grown at a double-digit rate in the past four quarters and has outperformed Wall Street’s expectations.
- CNBC Videos•10 days ago
Cramer on how to play the possible outcomes of Trump-Xi m...
Jim Cramer breaks down all the possible outcomes of U.S.-China trade talks at the G-20 summit and tells investors the best way to play the developments.
- CNBC Videos•10 days ago
Playing possible outcomes of Trump-Xi meeting at G-20
Jim Cramer breaks down all the possible outcomes of U.S.-China trade talks at the G-20 summit and tells investors the best way to play the developments.
